Gross margins held at 60%, but 237 days of inventory suggests they are building a bridge to nowhere while net debt doubles.
Thesis: MCHP is executing a dangerous high-wire act: maintaining 60% gross margins by starving the channel while bloating their own balance sheet to historic levels. The 'strategic' inventory defense masks a structural problem—when lead times compress to 8 weeks, you lose pricing power. They are betting the company's leverage on a V-shaped recovery they explicitly admit they cannot predict. This is a working capital trap disguised as a quality compounder.
Verdict: SHORT — Conviction: HIGH
Catalyst: The inevitable pricing crack when they are forced to liquidate the 237 days of inventory to service the doubled debt load.
Key Risk: A rapid, V-shaped macro recovery (PMI > 50) validates the inventory build and allows them to ship high-margin chips without discounting.
The Tell: The CEO's soliloquy inventing 'Cumulative Revenue Area Under the Curve' to explain why losing share relative to peers' peaks doesn't matter. Winners talk about the next quarter; losers talk about 19-quarter cumulative averages to smooth out their failure.
Friction Level: HIGH_FRICTION — Inventory quality. Bulls see 'strategic last-time buys' for high-margin chips; Bears see $650M of bloat that will crush pricing power when liquidated.
Report not found
The report data is no longer available. Please return to the archive.